SCHEMBL15877403

SCHEMBL15877403

Cc1ccc(C#Cc2ccc3ccccc3n2)nc1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.63
KCNH2 Q12809 3/20 0.63
TTR P02766 2/20 0.54
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HCRTR1 O43613 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 2/20 0.44
ALDH1A1 P00352 1/20 0.40
NCF1 P14598 2/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15877347 0.81 GRM5 (0.64) GRM5KCNH2TTRSMN1; SMN2CYP1A2
SCHEMBL15877102 0.80 GRM5 (0.63) GRM5KCNH2TTRNPC1RAB9A
SCHEMBL15877252 0.77 GRM5 (1.00) GRM5KCNH2TTRNPC1RAB9A
SCHEMBL15877625 0.76 GRM5 (0.58) GRM5KCNH2TTRNPC1RAB9A
SCHEMBL30833070 0.75 GRM5 (0.54) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL3955825 0.75 GRM5 (0.54) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL18685683 0.75 TTR (0.59) GRM5KCNH2TTRCYP1A2NCF1
SCHEMBL30824514 0.74 GRM5 (0.59) GRM5KCNH2TTRNPC1RAB9A
SCHEMBL12884286 0.74 GRM5 (0.65) GRM5KCNH2TTRNPC1RAB9A
Hydrochloric Acid SCHEMBL4309309 0.74 GRM5 (0.53) GRM5NPC1RAB9ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946431-B2 2-(substituted ethynyl)quinoline derivatives as mGLUr5 antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-02-03 US claimed
US-20140206876-A1 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-07-24 US claimed
US-8946431-B2 2-(substituted ethynyl)quinoline derivatives as mGLUr5 antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-02-03 US disclosed
US-20140206876-A1 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140206876-A1 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists GRM5, GRIK5, GRIA4 GRM5 1/4885KCNH2 1318/4885TTR 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.